Terumo | 4543 - Sales Revenues


Terumo reported JPY311.81B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Astellas Pharma JPY 629.95B 10.96B Sep/2026
Chugai Pharma JPY 404.7B 63.1B Sep/2026
Daiichi Sankyo JPY 592.49B 17.75B Sep/2026
Eisai JPY 235.63B 1.3B Sep/2026
Kyowa Hakko Kirin JPY 121.3B 23.86B Sep/2026
M3 JPY 91.75B 1.64B Sep/2026
Olympus JPY 269.19B 28.79B Sep/2026
Otsuka Holdings JPY 710.05B 8B Sep/2026
Shionogi JPY 187.07B 23.76B Sep/2026
Sumitomo Dainippon JPY 137B 7.5B Sep/2026
Takeda JPY 1.19T 32.9B Sep/2026
Terumo JPY 311.81B 11.49B Jun/2026